New study identifies who is most likely to use whole systems traditional Chinese Medicine during IVF

A recent study conducted by University Hospitals Connor Whole Health and the UH Fertility Center has uncovered key factors that influence the likelihood of women using Whole Systems Traditional Chinese Medicine (WS-TCM) during in vitro fertilization (IVF). WS-TCM encompasses services such as acupuncture, lifestyle medicine, counseling, nutritional guidance, and the use of herbs and supplements.

The research, published in F&S Reports, identified chronic pain conditions, a history of recurrent pregnancy loss, and previous experiences with multiple IVF cycles as significant predictors of WS-TCM adoption.

Women experiencing chronic pain from migraines, headaches, musculoskeletal issues, or pelvic discomfort, as well as those with a documented history of recurrent pregnancy loss, were more inclined to incorporate WS-TCM into their IVF treatment. Furthermore, women residing in higher-income areas and those who had undergone three or more prior ART (Assisted Reproductive Technology) cycles also demonstrated a higher propensity for using WS-TCM.

Conversely, higher body mass index, the use of preimplantation genetic testing, as well as a history of pelvic inflammatory disease or high-risk pregnancy supervision were linked to lower WS-TCM utilization rates.

The study's lead author, Christine Kaiser, emphasized the importance of these findings in enhancing access to integrative fertility care. She highlighted the need to address the specific needs of patients facing additional challenges, such as chronic pain and recurrent pregnancy loss, through comprehensive whole-person care. Dr. Kristi Artz, vice president of Connor Whole Health, stressed the significance of understanding patient preferences and barriers, which can help reduce obstacles and ensure broader access to tailored reproductive care.